Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms

Charly Courdy(Centre National de la Recherche Scientifique), Carine Joffre(Inserm)
Research Square
August 9, 2022
Cited by 0


Related Papers